Home › Kanser ng Endometrium › Minnesota › Minneapolis

Pag-aaral pangklinika para sa Kanser ng Endometrium sa Minneapolis, MN

Isang pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Minneapolis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Nagre-recruitPhase 2

Abbott-Northwestern Hospital, Minneapolis
Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi ang layo

Lahat ng edad · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05564377

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Nagre-recruitPhase 3

Abbott-Northwestern Hospital, Minneapolis
Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Okt 2, 2026 · NCT07198074

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 2

Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06172478

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Nagre-recruitPhase 2

Abbott-Northwestern Hospital, Minneapolis
Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi ang layo

Edad 18 pataas · Kababaihan · Na-update Set 28, 2026 · NCT05112601

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Nagre-recruitPhase 3

Minnesota Oncology Hematology, PA ( Site 8003), Minneapolis

Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT06952504

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Nagre-recruitPhase 3

USOR - Minnesota Oncology/ Minneapolis Clinic, Minneapolis
USOR - Minnesota Oncology, Minneapolis

Edad 18 pataas · Kababaihan · Na-update Set 9, 2026 · NCT07166094

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Nagre-recruitPhase 3

Research Site, Minneapolis

Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT06989112

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1

University of Minnesota Masonic Cancer Center, Minneapolis

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07216105

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Nagre-recruitPhase 1

University of Minnesota, Minneapolis

Edad 15 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Nagre-recruitPhase 1/2

University of Minnesota/Masonic Cancer Center, Minneapolis

12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Nagre-recruitPhase 1

Normunity Investigational Site, Minneapolis

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07182149

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

M Health Fairview University of Minnesota Medical Center, Minneapolis

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05919264

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Nagre-recruitPhase 1/2

M Health Fairview University of Minnesota Medical Center, Minneapolis

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06330064

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Nagre-recruitPhase 3

Research Site, Minneapolis

Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Nagre-recruitPhase 2

518, Minneapolis

Edad 18 pataas · Kababaihan · Na-update Hul 16, 2026 · NCT06906341

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

Nagre-recruitPhase 1

University of Minnesota, Minneapolis

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05103683

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Allina Health Cancer Institute, Minneapolis

Edad 40 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT05366881

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Nagre-recruitPhase 2/3

Minnesota Oncology Hematology, P.A., Minneapolis

Edad 18 pataas · Kababaihan · Na-update May 2, 2024 · NCT05797831

Pag-aaral para sa Kanser ng Endometrium sa ibang lungsod

Iba pang pag-aaral sa Minneapolis

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.